Endoquest robotic system gets FDA OK to launch clinical trial
December 13, 2024
A pivotal study of the robotic platform in colorectal surgery will begin at five hospitals in early 2025.
A pivotal study of the robotic platform in colorectal surgery will begin at five hospitals in early 2025.
In the future, delivering therapeutic drugs exactly where they are needed within the body could be the task of miniature robots. Not little metal humanoids or even bio-mimicking robots; think instead of tiny bubble-like spheres.
Karl Storz announced the U.S. launch of Pathway.AI, a new operating room tool offered in partnership with Artisight.
EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical robot.
Stereotaxis (NYSE:STXS) announced today that its Magbot magnetic navigation ablation catheter received regulatory approval in China.
Stereotaxis (NYSE:STXS) announced today that its Genesis surgical robot received regulatory approval in China.
Globus Medical (NYSE:GMED) announced that launched its ExcelsiusHub navigation system for robotic surgical procedures.
FREMONT, Calif., Nov. 18, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the LinkSymphoKnee (LSK) from Waldemar Link GmbH & Co. KG, Germany (LINK) under a Collaboration Agreement between the two companies.
Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption (IDE).
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Nov. 11, 2024 /PRNewswire/ — Momentis Surgical Ltd., a leader in robotic-assisted surgical innovation, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its second-generation Anovo® robotic surgical platform.